Barriers to statin use in the Philippines

Maja Marcus and colleagues (March, 2022)1 show that, between 2013 and 2019, 41 low-income and middle-income countries (LMICs) failed to meet the WHO targets for statin use in preventing cardiovascular disease. We write from the perspective of the Philippines—a southeast Asian LMIC, where cardiovascu...

Full description

Bibliographic Details
Main Authors: Feliciano, Katrina T, Dychiao, Robyn Gayle K, Eala, Michelle Ann B, Paguio, Joseph Alexander, Guinto, Renzo R *
Format: Article
Published: Elsevier 2022
Subjects:
Online Access:http://eprints.sunway.edu.my/2209/
_version_ 1848802225579622400
author Feliciano, Katrina T
Dychiao, Robyn Gayle K
Eala, Michelle Ann B
Paguio, Joseph Alexander
Guinto, Renzo R *
author_facet Feliciano, Katrina T
Dychiao, Robyn Gayle K
Eala, Michelle Ann B
Paguio, Joseph Alexander
Guinto, Renzo R *
author_sort Feliciano, Katrina T
building SU Institutional Repository
collection Online Access
description Maja Marcus and colleagues (March, 2022)1 show that, between 2013 and 2019, 41 low-income and middle-income countries (LMICs) failed to meet the WHO targets for statin use in preventing cardiovascular disease. We write from the perspective of the Philippines—a southeast Asian LMIC, where cardiovascular disease has been the leading cause of death for the past 33 years.2 Challenges in health financing, health infrastructure, and health-service delivery are among the substantial barriers to increasing statin use in the country. We hope the Philippine can perspective inform policies that tackle issues surrounding statin use in other LMICs.
first_indexed 2025-11-14T21:19:58Z
format Article
id sunway-2209
institution Sunway University
institution_category Local University
last_indexed 2025-11-14T21:19:58Z
publishDate 2022
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling sunway-22092023-05-17T23:43:03Z http://eprints.sunway.edu.my/2209/ Barriers to statin use in the Philippines Feliciano, Katrina T Dychiao, Robyn Gayle K Eala, Michelle Ann B Paguio, Joseph Alexander Guinto, Renzo R * RA Public aspects of medicine RM Therapeutics. Pharmacology Maja Marcus and colleagues (March, 2022)1 show that, between 2013 and 2019, 41 low-income and middle-income countries (LMICs) failed to meet the WHO targets for statin use in preventing cardiovascular disease. We write from the perspective of the Philippines—a southeast Asian LMIC, where cardiovascular disease has been the leading cause of death for the past 33 years.2 Challenges in health financing, health infrastructure, and health-service delivery are among the substantial barriers to increasing statin use in the country. We hope the Philippine can perspective inform policies that tackle issues surrounding statin use in other LMICs. Elsevier 2022-06 Article PeerReviewed Feliciano, Katrina T and Dychiao, Robyn Gayle K and Eala, Michelle Ann B and Paguio, Joseph Alexander and Guinto, Renzo R * (2022) Barriers to statin use in the Philippines. The Lancet, 10 (6). e793. ISSN 1474-547x https://www.sciencedirect.com/science/article/pii/S2214109X22002017?via%3Dihub 10.1016/S2214-109X(22)00201-7
spellingShingle RA Public aspects of medicine
RM Therapeutics. Pharmacology
Feliciano, Katrina T
Dychiao, Robyn Gayle K
Eala, Michelle Ann B
Paguio, Joseph Alexander
Guinto, Renzo R *
Barriers to statin use in the Philippines
title Barriers to statin use in the Philippines
title_full Barriers to statin use in the Philippines
title_fullStr Barriers to statin use in the Philippines
title_full_unstemmed Barriers to statin use in the Philippines
title_short Barriers to statin use in the Philippines
title_sort barriers to statin use in the philippines
topic RA Public aspects of medicine
RM Therapeutics. Pharmacology
url http://eprints.sunway.edu.my/2209/
http://eprints.sunway.edu.my/2209/
http://eprints.sunway.edu.my/2209/